CONTENTS OF "NUTRITIONAL SCIENCE
OF SOY PROTEIN
(JAPAN) Vol. 10, No. 1, 1989"
(10-1) Autoacylation of soy proteins.

(10-2) Improvements of the functional properties of soy protein by heating in dry state.

(10-3) Studies on tofuyo flavor using soy protein isolate: Changes in free amino acids, reducing sugars and organic acids.

(10-4) Further improvement in function of soy protein as antioxidant and its application to prevention of linolenate peroxidation.

(10-5) Entry of intake protein-derived nitrogen into the body : A study with 15N-labelled soy protein.

(10-6) Effects of long-term feeding of soy protein isolate on proteinuria and age-related changes in some physiological variables in adult rats under ad libitum feeding condition.

(10-7) Effects of dietary proteins on enzyme and mRNA levels of lipogenic enzymes in rat liver.

(10-8) Chronic administration of soy protein isolate and ethanol enhanced carcinogenic index on dimethylnitrosamine metabolism in the rabbit liver microsomes.

(10-9) Hypocholesterolemic effects of undigested fractions of soybean protein in rats.

(10-10) Species difference in the effects of dietary protein on cholesterol metabolism.

(10-11) Liver cholesterol-lowering activity of soybean protein isolate in rats.

(10-12) Hypocholesterolemic effects of soy protein : Effects of dietary protein level on fatty acid profiles of phosphatidylcholine and fecal steroid excretion in rats.

(10-13) Nutritional specificity of soy protein isolate for cholesterol metabolism in rats.

(10-14) Effects of soybean on lipid digestibility and fecal excretion of neutral sterols in young men on a high-cholesterol diet.

(10-15) Availability of soy protein peptide in enteral nutrition.

(10-16) Demineralization of enzymic hydrolysate of SPI (Hinute PM) and absorption of desalted preparation in rat small intestine in vitro.

(10-17) Availability of soy protein peptides for total enteral nutrition.

(10-18) Effects of nitrogen supplement using soybean peptide on diet therapy with energy restriction to obese children.

(10-19) Effects of soy protein diet (20 g/day) on plasma and lipoprotein lipids based on Apo E phenotypes.

(10-20) Effect of SPI intake on plasma somatomedin C concentration in rats.

(10-21) Metabolic fates of carbon skeletons of amino acids in growing rats fed on the soy protein isolate diets.

(10-22) Effects of SPI or SPI hydrolysate diet on the resistance to streptococcal infection in mice.

(10-23) Effect of soy protein isolate on amelioration of nutritional status in portacaval shunted rats.

(10-24) Effect of soy protein diet in patients with liver cirrhosis.

(10-25) Usefulness of soy peptide in the patients with Crohn's disease.

(10-26) The long-term effect of soy protein on glucose utilization and insulin sensitivity of the peripheral tissue.

Index
Vol. 1 Vol. 2 Vol. 3 Vol. 4 Vol. 5 Vol. 6 Vol. 7 Vol. 8 Vol. 9
Vol.10 Vol.11 Vol.12 Vol.13 Vol.14 Vol.15 Vol.16 Vol.17 Vol.18 Vol.19
Vol.20 Vol.21 Vol.22 Vol.23 Vol.24 Vol.25 Vol.26 Vol.27 Vol.28 Vol.29
Vol.30 Vol.31 Vol.32 Vol.33 Vol.34 Vol.35 Vol.36 Vol.37 Vol.38  

For particulars, please inquire to Fuji Foundation for Protein Research


Fuji Foundation for Protein Research (Japan) Home page